Text Size

Osteoporosis Research Registry

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
Rehabilitation Institute of Chicago
Information provided by (Responsible Party):
Thomas J. Schnitzer, Northwestern University
ClinicalTrials.gov Identifier:
NCT01223300
First received: October 14, 2010
Last updated: July 26, 2012
Last verified: July 2012
History of Changes
  Purpose

The aim of this research registry is to collect information on individuals with osteoporosis, those with risk factors for osteoporosis, and comparative healthy controls. Bone mineral density measurements will be done on these individuals to determine bone health.


Condition
Osteoporosis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Osteoporosis Research Registry

Resource links provided by NLM:

MedlinePlus related topics: Osteoporosis
U.S. FDA Resources

Further study details as provided by Northwestern University:

Primary Outcome Measures:
  • BMD [ Time Frame: 0 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Bone markers [ Time Frame: 0 months ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Two (10 ml) blood samples


Estimated Enrollment: 200
Study Start Date: November 2008
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Osteoporosis
Healthy controls

Detailed Description:

The goal of this project is to develop a registry of research subjects with OP, with a risk of developing OP, and healthy controls. DXA scans will be performed on willing individuals at the spine, hips, and forearms and possibly the legs and heels in order to determine BMD. Subjects will also be asked to provide two (10 ml) blood samples, which may be used to analyze Vitamin D levels and/or other bone markers. By participating in the registry, subjects will be considered for current and future clinical research studies.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Individuals with osteoporosis or at risk for osteoporosis. Also, healthy controls.

Criteria

Inclusion Criteria:

  • Any subjects who give written informed consent

Exclusion Criteria:

  • Any individual who is not willing or able to give written informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01223300

Locations
United States, Illinois
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
Rehabilitation Institute of Chicago
Investigators
Principal Investigator: Thomas J Schnizter, M.D., PhD Northwestern University
  More Information

No publications provided

Responsible Party: Thomas J. Schnitzer, professor, Northwestern University
ClinicalTrials.gov Identifier: NCT01223300     History of Changes
Other Study ID Numbers: STU00007523
Study First Received: October 14, 2010
Last Updated: July 26, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on May 16, 2013